130 related articles for article (PubMed ID: 19704265)
1. In vivo effects of nonoxynol-9 on endometrial immune cell populations.
Rahangdale L; Greenblatt RM; Perry J; Darragh TM; Kobayashi A; Smith-McCune KK
J Acquir Immune Defic Syndr; 2009 Sep; 52(1):137-9. PubMed ID: 19704265
[No Abstract] [Full Text] [Related]
2. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects.
Stafford MK; Ward H; Flanagan A; Rosenstein IJ; Taylor-Robinson D; Smith JR; Weber J; Kitchen VS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):327-31. PubMed ID: 9525433
[TBL] [Abstract][Full Text] [Related]
3. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
Su HI; Schreiber CA; Fay C; Parry S; Elovitz MA; Zhang J; Shaunik A; Barnhart K
Contraception; 2011 Nov; 84(5):525-32. PubMed ID: 22018129
[TBL] [Abstract][Full Text] [Related]
4. Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina).
Patton DL; Kidder GG; Sweeney YC; Rabe LK; Hillier SL
Am J Obstet Gynecol; 1999 May; 180(5):1080-7. PubMed ID: 10329859
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of nonoxynol-9 questioned.
Rep Med Guidel Outcomes Res; 2000 Aug; 11(16):5-6. PubMed ID: 11799994
[No Abstract] [Full Text] [Related]
6. Safety of three formulations of nonoxynol-9 containing vaginal spermicides. N-9 Formulation Preferences Study Group Committee.
Coggins C; Elias C
Int J Gynaecol Obstet; 2000 Mar; 68(3):267-8. PubMed ID: 10699202
[No Abstract] [Full Text] [Related]
7. [A clinical study of the local contraceptive C-Film Lucchini].
Porozhanova V; Bozhinova S; Khristova V
Akush Ginekol (Sofiia); 1999; 38(3):54-6. PubMed ID: 10734685
[TBL] [Abstract][Full Text] [Related]
8. Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study.
Smith-McCune K; Chen JC; Greenblatt RM; Shanmugasundaram U; Shacklett BL; Hilton JF; Johnson B; Irwin JC; Giudice LC
PLoS One; 2015; 10(7):e0129769. PubMed ID: 26177352
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive effectiveness and safety of five nonoxynol-9 spermicides: a randomized trial.
Raymond EG; Chen PL; Luoto J;
Obstet Gynecol; 2004 Mar; 103(3):430-9. PubMed ID: 14990402
[TBL] [Abstract][Full Text] [Related]
10. [Patentex Oval - a modern local contraceptive].
Sirakov M; Kolarov G
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():23-5. PubMed ID: 11519318
[No Abstract] [Full Text] [Related]
11. Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure.
Li Y; Yu S; Huang C; Lian R; Chen C; Liu S; Li L; Diao L; Markert UR; Zeng Y
Fertil Steril; 2020 Jan; 113(1):187-196.e1. PubMed ID: 31718829
[TBL] [Abstract][Full Text] [Related]
12. Self-reported discomfort associated with use of different nonoxynol-9 spermicides.
Feldblum PJ
Genitourin Med; 1996 Dec; 72(6):451-2. PubMed ID: 9038653
[No Abstract] [Full Text] [Related]
13. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
Mayersak JS; Viviano CJ
J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
[TBL] [Abstract][Full Text] [Related]
14. Nonoxynol-9 or Frankenstein?
Salyer D
Surviv News (Atlanta Ga); 2001 May; ():6. PubMed ID: 11682730
[No Abstract] [Full Text] [Related]
15. Nonoxynol-9 may increase HIV transmission risk.
Kirby J
Posit Living; 2001; 10(5):20. PubMed ID: 11693101
[No Abstract] [Full Text] [Related]
16. Disruption of the upper female reproductive tract epithelium by nonoxynol-9.
Dayal MB; Wheeler J; Williams CJ; Barnhart KT
Contraception; 2003 Oct; 68(4):273-9. PubMed ID: 14572891
[TBL] [Abstract][Full Text] [Related]
17. Study of the vaginal tolerance to Acidform, an acid-buffering, bioadhesive gel.
Amaral E; Faúndes A; Zaneveld L; Waller D; Garg S
Contraception; 1999 Dec; 60(6):361-6. PubMed ID: 10715372
[TBL] [Abstract][Full Text] [Related]
18. A phase I comparative study of three contraceptive vaginal films containing nonoxynol-9. Postcoital testing and colposcopy.
Mauck CK; Baker JM; Barr SP; Johanson WM; Archer DF
Contraception; 1997 Aug; 56(2):97-102. PubMed ID: 9315418
[TBL] [Abstract][Full Text] [Related]
19. Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.
Lozenski K; Ownbey R; Wigdahl B; Kish-Catalone T; Krebs FC
BMC Pharmacol Toxicol; 2012 Oct; 13():9. PubMed ID: 23025553
[TBL] [Abstract][Full Text] [Related]
20. The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers.
Marais D; Carrara H; Kay P; Ramjee G; Allan B; Williamson AL
Virus Res; 2006 Nov; 121(2):220-2. PubMed ID: 16860426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
